Drug news
EU approves Optisharp (DSM Nutritional Products) for nutritional use
The European Commission approved the use of nature-identical Optisharp (zeaxanthin), from DSM Nutritional Products, as an ingredient in food supplements as a way to improve visual performance. The decision follows a positive EFSA safety assessment delivered on September 13, 2012, which concluded that the use level for zeaxanthin does not raise safety concerns. Studies have suggested that high concentration of lutein and zeaxanthin in the macula is associated with reduced glare disability, improved photostress recovery, and contrast enhancement.